The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone [PDF]
Introduction: The best and effective iron chelation remain one of the major strategy in clinical management of thalassemia major patients. The purpose of this study was to evaluate the safety and effectiveness of combined therapy with Desferrioxamine and
Mohammad Ali Mashhadi +3 more
doaj +2 more sources
Combined therapy with deferiprone and desferrioxamine in thalassemia major [PDF]
BACKGROUND AND OBJECTIVES: Effective and convenient iron chelation remains one of the main targets of clinical management of thalassemia major. The combined treatment with desferrioxamine and deferiprone could have an increased chelation efficacy and ...
R Origa +8 more
doaj +3 more sources
Identification of Siderophores With Unexpected Antibacterial Properties From Actinoplanes teichomyceticus. [PDF]
Here, we report isolation of acyl‐desferrioxamines from Actinoplanes teichomyceticus as a mixture of iron and aluminum complexes. The fraction containing these molecules exhibited antibacterial activity. We synthesized these molecules and found that they only exhibited antibacterial activity in the presence of aluminum.
Oyedele AS +7 more
europepmc +2 more sources
The therapeutic opportunities and pitfalls of using iron ion chelators to treat neurodegenerative diseases. [PDF]
Although too much iron in the brain promotes neurodegeneration, iron ion chelators have had mixed effects in clinical trials. This review explains why; some chelators do not render the iron redox‐inactive (e.g., L1) whereas others do (e.g., desferrioxamine).
Halliwell B.
europepmc +2 more sources
Remodelling of Skeletal Muscle During Iron Deficiency Anaemia and Recovery After Intravenous Iron Therapy. [PDF]
ABSTRACT Background The global prevalence of iron deficiency anaemia (IDA) is about 25% and even higher in women of reproductive age and children. IDA can impair skeletal muscle by disrupting oxygen utilization, energy production and contractile function. Haematological effects of intravenous (IV) iron therapy in IDA are well studied, but its impact on
Pertler E +18 more
europepmc +2 more sources
Homo-/Heterodimeric Substrates Bias the Type and Multiplicity of Hydroxamic Acid Chelators Assembled by a NIS Synthetase DesD. [PDF]
Chemoenzymatic reactions using the siderophore synthetase DesD from Salinispora tropica and hydroxamic acid substrates (native, non‐native) with different multiplicities (monomer, dimer) and components (homo‐/heterodimer) followed different reaction trajectories, which biased the architectures of the chelator major products and indicated DesD contains ...
Rosser CA, Markham TE, Codd R.
europepmc +2 more sources
Contemporary Management of Thalassemia: A Perspective on Current Standards and the Emergence of FDA-Approved Oral Therapy. [PDF]
ABSTRACT Background and Aims Thalassemia is an inherited hemoglobin disorder characterized by ineffective erythropoiesis, chronic anemia, and progressive multisystem complications that require lifelong management. Current treatment relies on regular red blood cell transfusions, iron chelation therapy, and supportive multidisciplinary care, while ...
Zainab F, Hasan AH, Abid MH, Abid MA.
europepmc +2 more sources
Ocular Complications in Patients With Transfusion-Dependent Beta-Thalassemia Receiving Deferasirox: A Cross-Sectional Study. [PDF]
ABSTRACT Background and Aims Transfusion‐dependent beta‐thalassemia is a chronic hematologic disorder necessitating lifelong blood transfusions and iron chelation therapy, which can lead to systemic and ocular complications. This study aimed to assess the frequency and characteristics of ocular complications in beta‐thalassemia patients treated with ...
Medghalchi A +7 more
europepmc +2 more sources
Calibration and count rate performance of NaI(Tl) gamma counters for quantifying the activity <sup>89</sup>Zr radiopharmaceuticals. [PDF]
Abstract Background Quantification of low activity samples using gamma counters is a common technique when investigating the biodistribution of experimental radiopharmaceuticals. Several human and pre‐clinical trials have investigated 89Zr labeled compounds, utilizing gamma counter to quantify activity in blood or animal samples.
Silosky M.
europepmc +2 more sources
Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease. [PDF]
Oxidative stress is common in inflammatory processes associated with many diseases including Chagas' disease. The aim of the present study was to evaluate, in a murine model, biomarkers of oxidative stress together with components of the antioxidant ...
Olindo Assis Martins-Filho +30 more
core +1 more source

